NIBSC - January 2011 presentations

Enter a search term

Home Page > Spotlight > Standardisation of Genome Amplification Techniques > Clinical diagnostics > Past meetings > January 2011 presentations

January 2011 presentations

Return to previous page|

January 2011 presentations

Speaker	Title of Talk	Presentation
Introduction
Philip Minor	Welcome address
Session 1: Assessing assay variability through EQAS/Proficiency Testing/Data reporting
Giuseppe Vincini	NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens	View Presentation
Brigitte Senechal	A recent UK NEQAS pilot distribution highlights the need for standardisation of EBV DNA quantification	View Presentation
Catherine Thompson	Quality assurance panels for influenza virus detection and typing: Experiences from the UK and Europe	View Presentation
William MacKay	Supporting standardisation through external quality assessment when no international standard is available	View Presentation
Session 2: Development, use and calibration of secondary reference reagents
Anna Gottlieb	Clinical diagnostic working reagents – future developments	View Presentation
Peter Simmonds	Update on Clinical Virology Network (CVN) Development Programme – Current status, reagents and bioinformatic resources	View Presentation
Session 3: Development and use of higher order reference materials for clinical pathogens
Jacqueline Fryer	Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification (NAT)-Based Assays	View Presentation
Jacqueline Fryer	Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Epstein-Barr Virus (EBV) for Nucleic Acid Amplification (NAT)-Based Assays	View Presentation
Michael Chudy	Development of an International Reference Preparation for Hepatitis D Virus RNA - Update	View Presentation
Micha Nübling	WHO IS for Mycoplasma NAT	View Presentation
Jacqueline Fryer	New proposals for WHO International Standards for Human Herpesvirus 6 and Adenovirus	View Presentation
Angela Caliendo	The need for an Aspergillus Standard	View Presentation
Rob Schuurman	Universal controls to calibrate quantitative real-time PCR based assays; Overcoming the need for specific International Standards?	View Presentation
George Schneider	A universal internal control for molecular assays derived from a pumpkin plant gene	View Presentation
Ken Mutton	Use of internal controls in clinical PCR assays	View Presentation
Session 4: Technical aspects of molecular assays relating to standardisation
Christine Ginocchio	Standardization of Quantitative Assays for Respiratory Viruses	View Presentation
Nick Parham	Evaluation of automated nucleic acid isolation methods for molecular diagnostics	View Presentation
Rory Gunson	Multiplex Real Time PCR: The Good, The Bad And The Downright Ugly	View Presentation
Session 5: Regulatory issues
Robyn Wood	Sensible Regulation – is it possible? How Australia has chosen to regulate in-house IVDs	View Presentation
Giuseppe Vincini	NRL’s role in IVD regulation in Australia	View Presentation
Francisco Martínez-Murillo	Regulation of POCT and LDTs, an FDA’s perspective	View Presentation
Micha Nübling	Revisions to the IVD Directive – Impact on clinical diagnostics	View Presentation

January 2011 presentations

January 2011 presentations

Speaker

Title of Talk

Presentation